StockData
Lipella Pharmaceuticals Inc. logo

Lipella Pharmaceuticals Inc. (LIPO) shareholders

LIPOOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2025, quý kết thúc ngày Sep 30, 2025Last filing: 10-Q on Nov 14, 2025Score 6/30
$0.00+0.00 (0.00%)

Close on Oct 19, 2026Market cap $2.27KP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2025, from 13F filings

Held by institutions
0.0%
0M of 5M shares
Institutional holders
0
0 new, 3 sold out
Net institutional buying
-0M
In Q2 2025
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Shares held by institutions

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 202500M0.0%0 / 00 / 30M0M
Q1 202530M0.1%1 / 00 / 10M0M
Q4 202430M0.3%3 / 00 / 00M0M

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Jonathan H. KaufmanSee remarks below., Director, 10% owner898,84919.45%Apr 7, 2025

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Jonathan H. Kaufman
See remarks below., Director, 10% owner
May 14, 2024Buy+10,000$0.76$7.60K898,849
Jonathan H. Kaufman
See remarks below., Director, 10% owner
Mar 19, 2024Buy+25,000$0.87$21.75K888,849
Jonathan H. Kaufman
See remarks below., Director, 10% owner
Mar 18, 2024Buy+30,000$0.79$23.70K863,849
Michael B. Chancellor
Chief Medical Officer, Director, 10% owner
Mar 13, 2024Award+144,906$0.69$99.99K877,637
Jonathan H. Kaufman
See remarks below., Director, 10% owner
Mar 13, 2024Award+144,906$0.69$99.99K833,849
Michael B. Chancellor
Chief Medical Officer, Director, 10% owner
Dec 22, 2022Other+22,950$5.75$131.96K732,730

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of shares outstanding
–
0M shares short
Days to cover
1.9
At 0M shares a day
Change since last report
-0.1%
From 0M shares
Short volume, 20 days
41.7%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Lipella Pharmaceuticals's stock actually held short. Settlement fails (shares not delivered on time) peaked at 234 shares on Oct 13, 2026 over the last 90 days.

See a number that looks wrong?